The Caring Ambassadors supports individuals in gaining control of their health care, regardless of the illness they face.

We provide information, tools, and resources to help those with any chronic health condition not only manage their health care after a diagnosis, but improve their quality of life and capacity for healing.

As an advocacy organization, we both fight for patient rights and work to build a new generation of patient and health care champions.

Our disease specific programs for Hepatitis C and Lung Cancer have been helping people obtain the support, assistance, and information they need for over 20 years.

The Caring Ambassadors Lung Cancer Program provides this website to help you and your loved ones understand your disease and some of the health care options available to you.
Knowledge empowers you to ask the necessary questions to become your own best advocate.

The Caring Ambassadors Hepatitis C Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
We are honored to serve the community to help eliminate the largest infectious disease outbreak of our time

MY CHOICES© is a tool to help you recognize and act upon what you can control in your health care journey to achieve optimal healing, regardless of the illness you face. It contains elements of a guide book, health planner, journal, and activity book to help orient you to and plan for the journey ahead.

AmazonSmile is a website operate by Amazon with the same products, prices and shopping features as The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products. 

The time is now. 71 million people worldwide are living with chronic Hepatitis C right now. It is the largest chronic infectious disease outbreak of our time…and it’s curable. Talk to your doctor about treatment for your Hepatitis C, and don’t take no for an answer

Hey Oregon.  At a time when drug pricing is a top priority for Congress and the White House, we wanted toshare our thoughts on several recent proposals. Tag Oregon Senators and Congressional delegation and share our letter!

Weekly News Update.
Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.

My Choices© Update
Week Ending December 9, 2019

Health Tip: 4-7-8 Breath Relaxation Exercise
“Breathing exercises can help you relax and manage stress, says the Arizona Center for Integrative Medicine. The center suggests using the 4-7-8 breath exercise.”

7 Home Remedies to Boost Your Immune System
“Fall and winter usher in the cold and flu season, so it’s important to boost your immune system to protect from viruses and germs. With the busy holiday social season, you need to be especially careful since you are much more likely to come into contact with folks sniffling and sneezing.”

How Long Does Chemotherapy Stay in Your Body?
“Chemotherapy agents are powerful drugs that are used to treat cancer throughout the body. Chemotherapy drugs work by a variety of different mechanisms, but their general effect is to slow or stop the growth of cancer cells, which divide and proliferate quickly. Chemotherapy is administrated with the intention of eliminating cancer cells so that the infected body can survive and remain in remission.“

Marijuana Could Offer Relief From Migraine Pain
“Headache and migraine patients, take note: medical marijuana may help ease your pain.”

NIH study reports more than half of US office-based physicians recommend CHA
“A new study has shown that more than half (53.1%) of office-based physicians in the U.S., across specialty areas, recommended at least one complementary health approach (CHA) to their patients during the previous 12 months, with female physicians (63.2%) more likely to recommend a CHA than male physicians (49.3%).”

Dreams train brain for fearful real-life situations
“Bad dreams can help people react better to frightening situations when they’re awake, a finding that could lead to dream-based therapies for anxiety, Swiss researchers say.”

Plant-based Diets: What About Dairy?
“Plant-based diets might aid in the prevention and reversal of disease. People with Parkinson’s disease can benefit from plant-based diets.”

Botanicals in the limelight during scientists’ social media Q&A
“On Nov. 8, National Institutes of Health (NIH) scientists from NIEHS, the National Center for Complementary and Integrative Health (NCCIH), the NIH Office of Dietary Supplements (ODS), and others joined science enthusiasts on the social media platform Reddit.”

How to Eat, Sleep and Live Better, with Dr. Andrew Weil M.D.
“Dr. Andrew Weil M.D. is nothing less than a legendary leader within the field of integrative and botanical medicine. Now, at 77 years old, he’s still the perfect picture of health.”

Hepatitis C News
Week Ending December 9, 2019

Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations
‘Background: Hepatitis C virus (HCV) disproportionately affects disadvantaged communities. Objective: To examine processes and outcomes of Screen, Treat, Or Prevent Hepatocellular Carcinoma (STOP HCC), a multicomponent intervention for HCV screening and care in safety-net primary care practices.’

Glecaprevir and Pibrentasvir Helps HCV Patients with Treatment Failure
‘While treatment options remain limited after failure of sofosbuvir with an NS5A inhibitor for patients with hepatitis C virus (HCV) infections, new data points to glecaprevir/pibrentasvir (G/P) as a potential option for these patients.’

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis
‘HCV reinfection following successful treatment can compromise treatment outcome. This systematic review assessed the rate of HCV reinfection following treatment among people with recent drug use and those receiving opioid agonist therapy (OAT).’

How 5 health systems are using their 340B savings
‘A report released Dec. 4 by 340B Health shows how hospitals that receive 340B program funding are using their savings to improve patient outcomes. The 340B drug pricing program was created in 1992 to make sure hospitals that serve large populations of low-income, Medicaid, uninsured and under-insured patients could continue to provide care regardless of patients’ ability to pay.’

Hepatitis C drug prescriptions and Medicaid policies–four states, Indian health care system, USA 2018
‘Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states.’

New Study has Global Impact on Hepatitis C Elimination Efforts
‘Chronic hepatitis C virus (HCV) affects over 70 million people worldwide and is a leading cause of cirrhosis and liver cancer. An estimated three to four million Americans have chronic HCV infection, with many of them being baby boomers born between 1945 and 1965.’

Lung Cancer News
Week Ending December 9, 2019

Immunotherapy’s next horizon: cancer prevention
“Teresa Powell learned she remained at high risk for lung cancer three years ago, after doctors removed an early-stage malignancy but testing still showed pre-disease growths.”

Department of Defense awards grant to Edmond researcher for lung cancer study
“OKLAHOMA CITY – Cancer researchers operate from a fundamental premise: Tumor cells are very smart. Because of their ability to disguise themselves, hide or otherwise evade the immune cells that can kill them, the key to successful treatment depends upon taking away those powers.”

Oncology Clinical Pathways: A Growing Trend for Value-Based Care
“Oncology clinical pathways (OCPs) have been part of a growing trend for providers and payers.  The American Society of Clinical Oncology (ASCO) reported a 42% increase from 2014 to 2016 in practices compliant with a pathway program based on an annual census of oncology practices.”

Young Investigators awarded $200k to study how the body’s own defense mechanisms may be used in the fight against lung cancer
“Lung Cancer Foundation of America, International Lung Cancer Foundation (ILC Foundation) fund two new Young Investigator grants focusing on immunotherapy”

Depression affects one-third of lung cancer patients
“Study finds impact on pain, hopelessness, day-to-day function
COLUMBUS, Ohio – About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.”

Genentech Earns Another Lung Cancer Approval for Tecentriq
“The U.S. Food and Drug Administration (FDA) approved Genentech’s Tecentriq plus chemotherapy as a first-line treatment of metastatic non-squamous non-small cell lung cancer. The approval is for patients who have no EGFR or ALK genomic tumor aberrations.”

Fighting lung cancer: How new therapies are improving outcomes
“Lung cancer remains the leading cause of cancer death in the United States. As a medical professional who deals with this widespread disease on a daily basis, I would like to share some of the new treatments and preventative measures we are taking to combat lung cancer and raise awareness of the disease.”

FDA Grants Priority Review to Durvalumab for Extensive-Stage Small Cell Lung Cancer
“The FDA has accepted a supplemental biologics license application (sBLA) and granted a priority review to Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC), according to AstraZeneca, the drug’s manufacturer.”

Checking Out Emerging Approaches in Lung Cancer Treatment in Chicago
“We recently traveled to Chicago, Illinois for a State of the Science Summit™ on Lung Cancer.”